As a bioscience innovation consultancy, we continually explore and pioneer consultancy services in exciting new areas that are expanding the possibilities – Blue Growth and Insects as Food and Feed are two examples where BioBridge has helped move innovations forward.
We are also strong in helping natural ingredients find their place in several different sectors including foods, nutraceuticals, cosmetics and industrial biotechnology.
For all our sectors of interest, we create business to business linkages and help put young, growing and established companies in touch with potential investors.
Marine biotechnology/Business development exploitation and dissemination
Meredith is advising a young company on business strategy for its activities in fish wastes valorisation and providing a market research study for the potentials of a novel technology platform. He will also be advising on commercialisation potential of research outputs for a Centre of Excellence of Biotechnology and Bioengineering.
Animal health/business and regulatory strategy
BioBridge Ltd was selected by HealthforAnimals (http://healthforanimals.org/), the global organisation representing the animal health and veterinary medicines industry, to manage its Global Benchmarking Survey, GBS 2015, following the successful GBS 2011. BioBridge’s international team of consultants, led by Meredith, brought the spotlight onto China and Brazil, in addition to the core countries of USA, Canada, Australia, Japan and the EU, in this overview and analysis of the state of innovation, the quality of interactions between the industry and the regulators, and prospects for innovation in the future.
Bioscience and other innovations
Meredith Lloyd-Evans has assisted public agencies in Europe, providing various services to ensure that their funded projects in innovation maintain high standards and are value-for-public-money. He is regarded as expert in application areas including food technology for improved health, industrial biotechnology, green chemistry, marine bioresource developments, bioprocessing, resource valorisation and advanced IT for independent living. With a strong focus on biobased industries and biomass utilisation, he has advised young companies in insect production, biopolymers from domestic wastes, biochar and energy from agricultural wastes.
Meredith is advisor on biosafety and supply chain security for 2 biomaterials companies, providing biosafety analysis, regular updates on disease dynamics and process state-of-the-art.
Human health/business development
BioBridge continues to work on identifying and analysing licensable products for companies including Japanese pharmaceutical and Nordic cosmeceutical, introducing product opportunities and potential licensors.
Marine biotechnology/research and science strategy and development
BioBridge was a partner in the EU-funded project PharmaSea (http://www.pharma-sea.eu/), aimed at increasing value and flow in the marine biodiscovery pipeline, where we helped exploitation strategy, best practice in access and benefit sharing, and dissemination activities. Meredith has worked on socioeconomic indicators for assessing the contribution and dynamics of marine biotechnology in Blue Growth.
2011-2013, BioBridge managed the EC-funded project CSA MarineBiotech, an ERA-NET preparatory action in marine biotechnology, successfully paving the way for the ERA-MBT itself www.marinebiotech.eu.
Meredith's work with EC Horizon 2020 NMBP panel is complete and the NMBP part of the Work Programme received the unanimous support of the Programme Committee and has been pre-published as a draft: https://ec.europa.eu/programmes/horizon2020/en/what-work-programme